Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Carmell Therapeutics Corp...

    NASDAQ: CTCX · Real-Time Price · USD
    0.20
    0.01 (2.77%)
    At close: Mar 07, 2025, 3:55 PM

    Carmell Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -15.45M -9.05M -6.48M
    Depreciation & Amortization
    		 124.79K 242.56K 242.12K
    Stock-Based Compensation
    		 667.68K 636.37K 246.8K
    Other Working Capital
    		 -2.97M 1.28M 872.37K
    Other Non-Cash Items
    		 9.73M 2.6M 1.35M
    Deferred Income Tax
    		 n/a -194.59K 2.52M
    Change in Working Capital
    		 -3.42M 2.34M 952.69K
    Operating Cash Flow
    		 -8.35M -3.43M -1.18M
    Capital Expenditures
    		 -30.47K -7.16K -7.27K
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 n/a n/a -154.44M
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a 154.44M
    Investing Cash Flow
    		 -30.47K -7.16K -7.27K
    Debt Repayment
    		 -3.2M 2.75M 1.12M
    Common Stock Repurchased
    		 n/a -2.29K n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 14.32M -256.34K 67.82K
    Financial Cash Flow
    		 11.16M 3.55M 1.2M
    Net Cash Flow
    		 2.78M 115.79K 11.21K
    Free Cash Flow
    		 -8.38M -3.44M -1.18M

    Add to Watchlist